Literature DB >> 3970793

Verapamil in primary pulmonary hypertension.

I Malcić, D Richter.   

Abstract

An 8 year old girl with primary pulmonary hypertension and signs of heart failure was given 17.5 mg of verapamil injected into the pulmonary artery over 25 minutes to test for the reversibility of pulmonary arteriolar obstruction. Pulmonary artery pressure fell from 70/50 to 35/25 mm Hg. Treatment with 40 mg verapamil by mouth four times daily was started, and she was discharged. She gradually became asymptomatic and resumed the activities of a normal child of school age. On recatheterisation seven months later her pulmonary artery pressure was 30/10 mm Hg. She was still doing well 12 months after the start of treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970793      PMCID: PMC481767          DOI: 10.1136/hrt.53.3.345

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  Primary pulmonary hypertension: beneficial therapy with diltiazem.

Authors:  H Kambara; K Fujimoto; A Wakabayashi; C Kawai
Journal:  Am Heart J       Date:  1981-02       Impact factor: 4.749

2.  Nifedipine in the treatment of primary pulmonary hypertension.

Authors:  J R Wise
Journal:  Am Heart J       Date:  1983-04       Impact factor: 4.749

3.  Fatal outcome following nifedipine for pulmonary hypertension.

Authors:  H W Farber; J B Karlinsky; L J Faling
Journal:  Chest       Date:  1983-04       Impact factor: 9.410

4.  Sustained beneficial effect of nifedipine in primary pulmonary hypertension.

Authors:  P J De Feyter; H J Kerkkamp; J P de Jong
Journal:  Am Heart J       Date:  1983-02       Impact factor: 4.749

5.  Rapid attenuation of response to nifedipine in primary pulmonary hypertension.

Authors:  B A Wood; F Tortoledo; J C Luck; W H Fennell
Journal:  Chest       Date:  1982-12       Impact factor: 9.410

6.  Nifedipine, a new antihypertensive with rapid action.

Authors:  M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

7.  Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs.

Authors:  I F McMurtry; A B Davidson; J T Reeves; R F Grover
Journal:  Circ Res       Date:  1976-02       Impact factor: 17.367

8.  Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension.

Authors:  C Mélot; R Naeije; P Mols; J L Vandenbossche; H Denolin
Journal:  Chest       Date:  1983-02       Impact factor: 9.410

9.  Primary pulmonary hypertension: effects of nifedipine.

Authors:  F Camerini; E Alberti; S Klugmann; A Salvi
Journal:  Br Heart J       Date:  1980-09

10.  Selectivity of calcium antagonistic action in vascular smooth muscle.

Authors:  C van Breemen; A Mangel; M Fahim; K Meisheri
Journal:  Am J Cardiol       Date:  1982-02-18       Impact factor: 2.778

  10 in total
  1 in total

1.  Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.

Authors:  N S Chan; J McLay; A C Kenmure
Journal:  Br Heart J       Date:  1987-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.